On the second anniversary of its launch, Ferring Pharmaceuticals’ REBYOTA remains a landmark innovation in the prevention of recurrent Clostridioides difficile.
The findings of a recent study suggest that while T. musculis can worsen asthma, it might also help the body fight off infections, offering potential for new treatments targeting the…
The skin can independently generate immune responses to control the microbiota and prevent infections, without relying on other immune centers.
Lonza's capsules ensures targeted intestinal delivery enhancing stability and therapeutic efficacy for LBPs and pharmaceutical applications.
Cmbio announces a strategic partnership with Nimble Science to deliver first in class high-quality, multi-omic data insights from the small intestine.
Nicola Segata, from University of Trento, investigates the intricate links between diet, microbiome composition, and cardiometabolic outcomes.
The findings suggest that the microbial communities inhabiting an infant’s nose and throat can play a role in the severity of RSV infections.
The findings suggest that bHB could be a therapeutic alternative to a ketogenic diet. The results also highlight the protective role of the gut microbiota and its metabolites in autoimmune…
Clara Delaroque, from Institut Pasteur (France), emphasizes the critical interplay between early-life microbiota and host health, specifically how the use of common food additives impacts the susceptibility to diseases later…
The presence of specific microbes in the gut microbiota can serve as biomarkers for predicting the efficacy of immunotherapy.
